In the skin of certain leopard geckos a white nodule appears, grows, returns after removal and sometimes spreads. For pet owners this has been a costly puzzle. For cancer researchers it has become an unexpected window into the disease.
On 15 July 2026 a team led by the University of Nottingham published the first detailed genomic portrait of these tumours. What they found was a set of molecular alterations that echo those seen across many human cancer types. The work rests on careful observation rather than forced laboratory models, an approach that aligns with long-standing biological tradition: let nature reveal its own experiments.
The lemon frost colour morph, created decades ago through selective breeding from a single spontaneous mutation, develops iridophoromas in more than 80 percent of individuals. These tumours of the pigment cells responsible for structural colour arise early, without any chemical or genetic induction in the lab. That natural onset matters. Most rodent models require artificial triggers that can obscure the very pathways researchers hope to study.
Whole-genome sequencing of tumour and healthy tissue from three affected geckos revealed several consistent changes. A missense mutation in the TATA-box binding protein gene, or TBP, stood out. It produces a threonine-to-lysine substitution at position 276 within the DNA-binding domain. Every tumour sample also carried the same fusion between the IARS1 and RNF213 genes. Regions of copy-number-neutral loss of heterozygosity affected three other genes already linked to cancer in humans: MAP3K13, TENM4 and an olfactory-receptor-like sequence. Gains appeared in four genomic intervals, including stretches housing zinc-finger proteins and the EPHB5 gene.
Pathway analysis pointed to disrupted actin filament organisation, a process tied to the ability of cells to migrate and metastasise. Tumour mutational burden fell between 2.99 and 5.26 mutations per megabase, a range comparable to the median observed in many human malignancies. Several of the altered pathways, among them transcriptional regulation, chromatin remodelling and cytoskeletal control, are familiar to oncologists.
By studying why some animals are so susceptible to cancer while others are remarkably resistant, we hope to uncover the different ways species have evolved to deal with cancer. Specifically, this gecko could become an incredible model in cancer research because tumours appear naturally at a relatively early age. Together, these natural strategies could inspire new ways of preventing, detecting, and treating cancer in humans.
Ylenia Chiari, associate professor in the School of Life Sciences at the University of Nottingham, led the study. Her team adapted the same genomic analysis tools developed for human tumours and showed they work across distant branches of the tree of life.
